Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence

Nature Communications

Volumn 6, Issue , 2015, Pages

  Yoong, Pauline ^a   Torres, Victor J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; ETHIDIUM BROMIDE; LACTATE DEHYDROGENASE; LEUKOTOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; BACTERIAL PROTEIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; LEUKOCIDIN S-COMPONENT PROTEIN, STAPHYLOCOCCUS; LUKD PROTEIN, STAPHYLOCOCCUS AUREUS; LUKE PROTEIN, STAPHYLOCOCCUS AUREUS; LUKF PROTEIN, STAPHYLOCOCCUS AUREUS; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

CELLS AND CELL COMPONENTS; HYBRID; IMMUNE SYSTEM; INHIBITION; NUTRIENT; PATHOGENICITY; TOXIN; VIRULENCE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; CELL MEMBRANE; CELLS BY BODY ANATOMY; CYTOTOXICITY; ERYTHROCYTE; FLUORESCENCE ACTIVATED CELL SORTING; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MACROPHAGE; NEUTROPHIL; NONHUMAN; NUTRIENT; PLASMID; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; CELL DEATH; CELL LINE; DRUG EFFECTS; GRANULOCYTE PRECURSOR; METABOLISM; MOUSE; VIRULENCE;

BACTERIA (MICROORGANISMS); MURINAE; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL DEATH; CELL LINE; ERYTHROCYTES; EXOTOXINS; GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKOCIDINS; MICE; NEUTROPHILS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84940873026     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9125     Document Type: Article

References (56)

1. Fridkin, S. K. et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352, 1436-1444 (2005).
2. Kallen, A. J. et al. Health care-Associated invasive MRSA infections, 2005-2008. JAMA. 304, 641-648 (2010).
3. Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948-958 (2005).
4. Otto, M. Basis of virulence in community-Associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143-162 (2010).
5. DeLeo, F. R. & Chambers, H. F. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119, 2464-2474 (2009).
6. Alonzo, 3rd F. & Torres, V. J. The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol. Mol. Biol. Rev. 78, 199-230 (2014).
7. Yoong, P. & Torres, V. J. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr. Opin. Microbiol. 16, 63-69 (2013).
8. Colin, D. A., Mazurier, I., Sire, S. & Finck-Barbancon, V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect. Immun. 62, 3184-3188 (1994).
9. Alonzo, 3rd F. et al. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493, 51-55 (2013).
10. Reyes-Robles, T. et al. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell. Host. Microbe. 14, 453-459 (2013).
11. Spaan, A. N. et al. The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors. Cell. Host. Microbe. 13, 584-594 (2013).
12. DuMont, A. L. & Torres, V. J. Cell targeting by the Staphylococcus aureus poreforming toxins: it's not just about lipids. Trends. Microbiol. 22, 21-27 (2014).
13. Miles, G., Movileanu, L. & Bayley, H. Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein. Sci. 11, 894-902 (2002).
14. Yamashita, K. et al. Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components. Proc. Natl Acad. Sci. USA 108, 17314-17319 (2011).
15. Spaan, A. N. et al. The staphylococcal toxins gamma-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat. Commun. 5, 5438 (2014).
16. DuMont, A. L. et al. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc. Natl Acad. Sci. USA 110, 10794-10799 (2013).
17. DuMont, A. L. et al. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect. Immun. 82, 1268-1276 (2014).
18. DuMont, A. L. et al. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79, 814-825 (2011).
19. McCarthy, A. J. & Lindsay, J. A. Staphylococcus aureus innate immune evasion is lineage-specific: a bioinfomatics study. Infect. Genet. Evol. 19C, 7-14 (2013).
20. Naimi, T. S. et al. Comparison of community-And health care-Associated methicillin-resistant Staphylococcus aureus infection. JAMA. 290, 2976-2984 (2003).
21. Ferreras, M. et al. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Biochim. Biophys. Acta. 1414, 108-126 (1998).
22. Morinaga, N., Kaihou, Y. & Noda, M. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol. Immunol. 47, 81-90 (2003).
23. Gravet, A. et al. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 436, 202-208 (1998).
24. Alonzo, 3rd F. et al. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol. Microbiol. 83, 423-435 (2012).
25. Loffler, B. et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS. Pathog. 6, e1000715 (2010).
26. Collins, S. J., Ruscetti, F. W., Gallagher, R. E. & Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl Acad. Sci. USA 75, 2458-2462 (1978).
27. DuMont, A. L. et al. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect. Immun. 81, 1830-1841 (2013).
28. Baba, T. et al. Genome and virulence determinants of high virulence community-Acquired MRSA. Lancet 359, 1819-1827 (2002).
29. Yoong, P. & Pier, G. B. Antibody-mediated enhancement of communityacquired methicillin-resistant Staphylococcus aureus infection. Proc. Natl Acad. Sci. USA 107, 2241-2246 (2010).
30. Haley, K. P. & Skaar, E. P. A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes. Infect. 14, 217-227 (2012).
31. Mazmanian, S. K. et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299, 906-909 (2003).
32. Torres, V. J., Pishchany, G., Humayun, M., Schneewind, O. & Skaar, E. P. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J. Bacteriol. 188, 8421-8429 (2006).
33. Torres, V. J. et al. Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect. Immun. 78, 1618-1628 (2010).
34. Pishchany, G. et al. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell. Host. Microbe. 8, 544-550 (2010).
35. Pishchany, G. et al. IsdB-dependent hemoglobin binding is required for acquisition of heme by Staphylococcus aureus. J. Infect. Dis. 209, 1764-1772 (2014).
36. Duthie, E. S. & Lorenz, L. L. Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6, 95-107 (1952).
37. Skaar, E. P., Humayun, M., Bae, T., DeBord, K. L. & Schneewind, O. Iron-source preference of Staphylococcus aureus infections. Science 305, 1626-1628 (2004).
38. Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F. R. & Schneewind, O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405-1406 (2007).
39. Torres, V. J. et al. A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell. Host. Microbe. 1, 109-119 (2007).
40. Wardenburg, J. B. & Schneewind, O. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205, 287-294 (2008).
41. Corbin, B. D. et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962-965 (2008).
42. Thammavongsa, V., Kern, J. W., Missiakas, D. M. & Schneewind, O. Staphylococcus aureus synthesizes adenosine to escape host immune responses. J. Exp. Med. 206, 2417-2427 (2009).
43. Inoshima, I. et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17, 1310-1314 (2011).
44. Thammavongsa, V., Missiakas, D. M. & Schneewind, O. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science 342, 863-866 (2013).
45. Chen, J., Yoong, P., Ram, G., Torres, V. J. & Novick, R. P. Single-copy vectors for integration at the SaPI1 attachment site for Staphylococcus aureus. Plasmid 76C, 1-7 (2014).
46. Bubeck Wardenburg, J., Patel, R. J. & Schneewind, O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75, 1040-1044 (2007).
47. Spaan, A. N., Surewaard, B. G., Nijland, R. & van Strijp, J. A. Neutrophils Versus Staphylococcus aureus: a Biological Tug of War. Annu. Rev. Microbiol. 67, 629-650 (2013).
48. Ozawa, T., Kaneko, J. & Kamio, Y. Essential binding of LukF of staphylococcal gamma-hemolysin followed by the binding of H gamma II for the hemolysis of human erythrocytes. Biosci. Biotechnol. Biochem. 59, 1181-1183 (1995).
49. Diep, B. A. et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl Acad. Sci. USA 107, 5587-5592 (2010).
50. Li, M. et al. Comparative analysis of virulence and toxin expression of global community-Associated methicillin-resistant Staphylococcus aureus strains. J. Infect. Dis. 202, 1866-1876 (2010).
51. Kobayashi, S. D. et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204, 937-941 (2011).
52. Lipinska, U. et al. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 6, e22864 (2011).
53. Bubeck Wardenburg, J., Palazzolo-Ballance, A. M., Otto, M., Schneewind, O. & DeLeo, F. R. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-Associated methicillin-resistant Staphylococcus aureus disease. J. Infect. Dis. 198, 1166-1170 (2008).
54. Yoong, P. & Pier, G. B. Immune-Activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect. Immun. 80, 2894-2904 (2012).
55. Malachowa, N. et al. Staphylococcus aureus Leukotoxin GH Promotes Inflammation. J. Infect. Dis. 206, 1185-1193 (2012).
56. Boles, B. R., Thoendel, M., Roth, A. J. & Horswill, A. R. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS ONE 5, e10146 (2010).